中华皮肤科杂志
中華皮膚科雜誌
중화피부과잡지
Chinese Journal of Dermatology
2013年
11期
831-833
,共3页
孙永新%方栩%崔炳南%黄琼%姜桂仙%戴媛媛%孔倩%都秀兰%朱广义
孫永新%方栩%崔炳南%黃瓊%薑桂仙%戴媛媛%孔倩%都秀蘭%硃廣義
손영신%방허%최병남%황경%강계선%대원원%공천%도수란%주엄의
目的 探讨卡泊三醇倍他米松软膏联合窄谱中波紫外线(NB-UVB)治疗斑块状银屑病的疗效及安全性.方法 随机、单盲平行对照、多中心临床试验,108例斑块状银屑病患者随机纳入试验组或对照组,疗程4周.对照组单纯进行NB-UVB照射;试验组NB-UVB照射方法同对照组,卡泊三醇倍他米松软膏每晚外用.治疗前、治疗2周、4周时观察疗效及安全性,治疗结束后1、2、4周进行随访.结果 两组患者治疗2周后,试验组有效率15.09%,对照组有效率2.04%,总体疗效分析差异有统计学意义.治疗4周后,试验组有效率77.36%,对照组26.53%,两组差异有统计学意义(P<0.01).治疗前两组PASI评分比较,差异无统计学意义;治疗2周、4周以及随访1周、2周、4周时,两组PASI评分比较,差异均有统计学意义.试验组未发现不良反应,对照组有1例双小腿非皮疹部位出现疼痛性红斑.两组间不良反应发生率比较,差异无统计学意义.结论 卡泊三醇倍他米松软膏联合NB-UVB治疗斑块状银屑病是一种见效快、安全的治疗方法.
目的 探討卡泊三醇倍他米鬆軟膏聯閤窄譜中波紫外線(NB-UVB)治療斑塊狀銀屑病的療效及安全性.方法 隨機、單盲平行對照、多中心臨床試驗,108例斑塊狀銀屑病患者隨機納入試驗組或對照組,療程4週.對照組單純進行NB-UVB照射;試驗組NB-UVB照射方法同對照組,卡泊三醇倍他米鬆軟膏每晚外用.治療前、治療2週、4週時觀察療效及安全性,治療結束後1、2、4週進行隨訪.結果 兩組患者治療2週後,試驗組有效率15.09%,對照組有效率2.04%,總體療效分析差異有統計學意義.治療4週後,試驗組有效率77.36%,對照組26.53%,兩組差異有統計學意義(P<0.01).治療前兩組PASI評分比較,差異無統計學意義;治療2週、4週以及隨訪1週、2週、4週時,兩組PASI評分比較,差異均有統計學意義.試驗組未髮現不良反應,對照組有1例雙小腿非皮疹部位齣現疼痛性紅斑.兩組間不良反應髮生率比較,差異無統計學意義.結論 卡泊三醇倍他米鬆軟膏聯閤NB-UVB治療斑塊狀銀屑病是一種見效快、安全的治療方法.
목적 탐토잡박삼순배타미송연고연합착보중파자외선(NB-UVB)치료반괴상은설병적료효급안전성.방법 수궤、단맹평행대조、다중심림상시험,108례반괴상은설병환자수궤납입시험조혹대조조,료정4주.대조조단순진행NB-UVB조사;시험조NB-UVB조사방법동대조조,잡박삼순배타미송연고매만외용.치료전、치료2주、4주시관찰료효급안전성,치료결속후1、2、4주진행수방.결과 량조환자치료2주후,시험조유효솔15.09%,대조조유효솔2.04%,총체료효분석차이유통계학의의.치료4주후,시험조유효솔77.36%,대조조26.53%,량조차이유통계학의의(P<0.01).치료전량조PASI평분비교,차이무통계학의의;치료2주、4주이급수방1주、2주、4주시,량조PASI평분비교,차이균유통계학의의.시험조미발현불량반응,대조조유1례쌍소퇴비피진부위출현동통성홍반.량조간불량반응발생솔비교,차이무통계학의의.결론 잡박삼순배타미송연고연합NB-UVB치료반괴상은설병시일충견효쾌、안전적치료방법.
Objective To assess the efficacy and safety of calcipotriol betamethasone ointment combined with narrow band-ultraviolet B (NB-UVB) for the treatment of plaque-type psoriasis.Methods A randomized,single-blind,parallel-controlled,multi-center clinical trial was conducted.Totally,108 patients with plaque-type psoriasis were randomly divided into the experiment group (treated with NB-UVB plus topical calcipotriol betamethasone ointment once daily in the evening) and control group (treated with NB-UVB only).The treatment lasted four weeks.The safety and efficacy were evaluated at the baseline,as well as two and four weeks after the beginning of treatment.Patients were scheduled for follow-up on week 1,2 and 4 after the end of treatment.Results The response rate was 15.09% in the experiment group and 2.04% in the control group after two-week treatment (P < 0.01),77.36% in the experiment group and 26.53% in the control group at the end of treatment (P < 0.01).Psoriasis area and severity index (PASI) score was similar between the two groups at the baseline,but significantly different from week 2 to week 8 after the beginning of treatment (all P < 0.0I).Adverse reaction was observed in none of these patients,except for one patient in the control group who developed painful erythema in non-lesional sites of both legs.There was no significant difference in the incidence of adverse reactions between the two groups.Conclusion Calcipotriol betamethasone ointment combined with NB-UVB is a safe and effective treatment choice for plaque-type psoriasis with rapid onset of action.